NFG
UTHR icon

Nations Financial Group’s United Therapeutics UTHR Stock Holding History

Nations Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
4,187
+71
+2% +$40K 0.11% 208
2026
Q1 		$2.44M Buy
4,116
+72
+2% +$35.9K 0.13% 189
2025
Q4 		$1.97M Buy
4,044
+524
+15% +$244K 0.1% 210
2025
Q3 		$1.48M Buy
3,520
+509
+17% +$171K 0.09% 237
2025
Q2 		$865K Buy
3,011
+77
+3% +$23K 0.06% 320
2025
Q1 		$904K Buy
2,934
+11
+0.4% +$3.77K 0.07% 294
2024
Q4 		$1.03M Buy
2,923
+19
+0.7% +$6.98K 0.08% 266
2024
Q3 		$1.04M Buy
2,904
+136
+5% +$45.9K 0.08% 271
2024
Q2 		$882K Buy
2,768
+1,329
+92% +$352K 0.07% 284
2024
Q1 		$331K Buy
1,439
+398
+38% +$89.8K 0.03% 513
2023
Q4 		$229K Buy
+1,041
New +$240K 0.02% 569

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nations Financial Group's UTHR Position: Q2 2026 in Review

Nations Financial Group increased its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, buying an estimated $40K and bringing the position to 4,187 shares worth $2.27M. The position accounts for 0.11% of the portfolio, ranked #208.

Nations Financial Group first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.44M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Nations Financial Group held 4,187 shares of United Therapeutics worth $2.27M as of Q2 2026.
  • Nations Financial Group bought 71 United Therapeutics shares in Q2 2026, an estimated $40K.
  • United Therapeutics made up 0.11% of Nations Financial Group's portfolio in Q2 2026, its #208 holding.
  • Nations Financial Group first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Nations Financial Group's United Therapeutics position peaked at $2.44M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.